Phase I-II study of F14512 in combination with cytarabine in patients 60 years old and older with acute myeloid leukemia
Phase I-II study of F14512 in combination with cytarabine in patients 60 years old and older with acute myeloid leukemia
Phase I-II study of F14512 in combination with cytarabine in patients 60 years old and older with acute myeloid leukemia
Status
Status :
Early termination
Type of study
Phase I / II
Min. Age
18
Years old
Max. Age
85
Years old
Gender
All
Therapeutic area :
Oncology
Disease :
Acute myeloid leukemia
Study medication :
F14512
Phase :
Phase I / II
Start Date :
09 April 2013
End date :
03 March 2017
Study ID :
F14512 IN 102 G1
EudraCT/CTIS number :
2012-005241-20
Send by email